“…In addition, there is marked inter and intra-subject variability in response to chronic therapies [ 239 , 240 , 241 , 242 ]. The CDP-based second-generation AI systems provide a platform for overcoming drug resistance and improving adherence by implementing variability-based therapeutic regimens for patients with chronic diseases [ 76 , 108 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 252 , 253 , 254 , 255 , 256 , 257 , 258 , 259 , 260 ]. The system enables personalized therapies based on individual variability signatures [ 146 , 239 , 257 , 261 ].…”